Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTL38 for Intra-operative Imaging in Ovarian Cancer
NCT02317705Phase 2Completed
- Sponsor
- On Target Laboratories
- Start
- Dec 2014
- Primary completion
- Nov 2015
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pafolacianine in ovarian cancer, sponsored by On Target Laboratories. Started Dec 2014; status: completed.
02
Drugs
pafolacianine
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT02317705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02317705.